Evie Koslosky
Stock Analyst at Goldman Sachs
(0.14)
# 4,564
Out of 5,241 analysts
9
Total ratings
16.67%
Success rate
-16.04%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Evie Koslosky
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RVTY Revvity | Maintains: Neutral | $110 → $95 | $93.97 | +1.10% | 2 | Apr 14, 2026 | |
| DHR Danaher | Maintains: Buy | $265 → $230 | $161.91 | +42.05% | 2 | Apr 13, 2026 | |
| BRKR Bruker | Maintains: Sell | $40 → $35 | $42.88 | -18.38% | 2 | Feb 13, 2026 | |
| MTD Mettler-Toledo International | Initiates: Neutral | $1,475 | $1,031.64 | +42.98% | 1 | Dec 9, 2025 | |
| A Agilent Technologies | Initiates: Buy | $170 | $111.70 | +52.19% | 1 | Dec 9, 2025 | |
| TMO Thermo Fisher Scientific | Initiates: Buy | $685 | $438.34 | +56.27% | 1 | Dec 9, 2025 |
Revvity
Apr 14, 2026
Maintains: Neutral
Price Target: $110 → $95
Current: $93.97
Upside: +1.10%
Danaher
Apr 13, 2026
Maintains: Buy
Price Target: $265 → $230
Current: $161.91
Upside: +42.05%
Bruker
Feb 13, 2026
Maintains: Sell
Price Target: $40 → $35
Current: $42.88
Upside: -18.38%
Mettler-Toledo International
Dec 9, 2025
Initiates: Neutral
Price Target: $1,475
Current: $1,031.64
Upside: +42.98%
Agilent Technologies
Dec 9, 2025
Initiates: Buy
Price Target: $170
Current: $111.70
Upside: +52.19%
Thermo Fisher Scientific
Dec 9, 2025
Initiates: Buy
Price Target: $685
Current: $438.34
Upside: +56.27%